AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
3.500
-0.050 (-1.41%)
At close: Dec 5, 2025, 4:00 PM EST
3.490
-0.010 (-0.29%)
After-hours: Dec 5, 2025, 6:32 PM EST
AVITA Medical Market Cap
AVITA Medical has a market cap or net worth of $106.73 million as of December 5, 2025. Its market cap has decreased by -68.59% in one year.
Market Cap
106.73M
Enterprise Value
128.19M
1-Year Change
-68.59%
Ranking
Category
Stock Price
$3.50
Market Cap Chart
Since October 2, 2019, AVITA Medical's market cap has decreased from $666.70M to $106.73M, a decrease of -83.99%. That is a compound annual growth rate of -25.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 106.70M | -68.21% |
| Dec 31, 2024 | 335.60M | -4.28% |
| Dec 29, 2023 | 350.60M | 112.23% |
| Dec 30, 2022 | 165.20M | -44.68% |
| Dec 31, 2021 | 298.60M | -25.68% |
| Dec 31, 2020 | 401.80M | -52.81% |
| Dec 31, 2019 | 851.40M | 27.70% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 901.83B |
| Johnson & Johnson | 487.23B |
| AbbVie | 400.97B |
| UnitedHealth Group | 299.79B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.73B |
| Merck & Co. | 248.08B |
| Abbott Laboratories | 217.76B |